conference paper
A NON-CD25-BINDING IL-2 VARIANT FOR THE EXPANSION OR ENGINEERING OF T CELLS THAT CONFER SUPERIOR TUMOR CONTROL
November 1, 2023
Human Gene Therapy
Cite this item
Miranda, Y. O., Masid, M., Luna, C. J., Montalvo Bereau, G. M., Muller, T., Rayroux, N., Cribioli, E., Corria-Osorio, J., Hope, H. C., Seijo, B., Ginefra, P., Leon, K., Vannini, N., Crespo, I., Hatzimanikatis, V., Irving, M., & Coukos, G. (2023). A NON-CD25-BINDING IL-2 VARIANT FOR THE EXPANSION OR ENGINEERING OF T CELLS THAT CONFER SUPERIOR TUMOR CONTROL. Human Gene Therapy, 34(21-22), A21–A22. https://infoscience.epfl.ch/handle/20.500.14299/204944
Click Copy to copy the citation, or select the text manually.
Type
conference paper
Web of Science ID
WOS:001126435700053
Author(s)
Miranda, Y. Ortiz
Masid, M.
Luna, C. Jimenez
Montalvo Bereau, G. M.
Muller, T.
Rayroux, N.
Cribioli, E.
Corria-Osorio, J.
Hope, H. Carrasco
Seijo, B.
Date Issued
2023-11-01
Publisher
Publisher place
New Rochelle
Published in
Human Gene Therapy
Volume
34
Issue
21-22
Start page
A21
End page
A22
Subjects
Editorial or Peer reviewed
REVIEWED
Written at
EPFL
EPFL units
| Event name | Event place | Event date |
Seoul, SOUTH KOREA | NOV 17-19, 2022 | |
Available on Infoscience
February 21, 2024
Use this identifier to reference this record